Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (2149)	1/29/1998 10:10:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Stronger note of caution: Vasomax will never be approved. It won't even get close. Vasomax's only active ingredient is Phentolamine, a 45-year old generic drug which is ineffective in the treatment of erectile disfunction. Despite the controversy surrounding ORG, the organization is a true development-stage company. In other words, there are real scientists working on real products. Zonagen is a fraud and a scam with a long track record of questionable business practices. Zonagen has reacted quickly to the collapse of its stock price (by the astonishing announcement of a stock buyback - despite the fact that the company is losing millions, has negligible revenues, and STILL hasn't filed an NDA) but has been much less responsive when it comes to releasing clear infromation regarding Vasomax.